Mikasafe 250mg Injection
Marketer
S R Pharmaceuticals
Salt Composition
Amikacin (250mg)
Overview Mikasafe 250mg Injection
Cefamox 250mg Injection combats a broad spectrum of bacterial infections, including those affecting the urinary tract, bones, joints, lungs (such as pneumonia), brain, and bloodstream. This antibiotic is also prophylactically administered to hospitalized patients to ward off infection. Cefamox 250mg Injection inhibits bacterial proliferation. Administered intravenously (IV infusion) or intramuscularly by a healthcare professional, self-injection is strictly prohibited. Adherence to the prescribed dosage schedule is crucial; omitting doses or prematurely halting treatment can result in relapse or infection exacerbation. Common adverse effects include injection site inflammation and elevated blood urea nitrogen (BUN). Persistent side effects or lack of improvement necessitate consultation with your physician. High doses may rarely cause vertigo, nephrotoxicity, and ototoxicity. Your doctor may conduct routine kidney, hearing, and urine tests throughout your treatment. This medicine is contraindicated during pregnancy; disclose pregnancy, pregnancy planning, or breastfeeding to your physician.
Uses of Mikasafe 250mg Injection
Infections caused by bacteria
Major Benefits of Mikasafe 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Mikasafe 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikasafe 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Mikasafe 250mg Injection works:
Cefamandole nafate 250mg injection is a bactericidal antibiotic. Its mechanism of action involves inhibiting bacterial protein synthesis, thus disrupting crucial bacterial processes.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Mikasafe 250mg Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Mikasafe 250mg Injection during pregnancy is contraindicated due to established fetal risks. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Administration of Mikasafe 250mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Administering Mikasafe 250mg Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Mikasafe 250mg Injection. Dosage modification of Mikasafe 250mg Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Mikasafe 250mg Injection in individuals with hepatic impairment is likely safe. Preliminary evidence indicates dose modification may not be necessary. However, physician consultation is recommended.
What if you forget to take Mikasafe 250mg Injection :
Omit a scheduled dose of Mikasafe 250mg Injection? Seek medical advice immediately.
Facts to Know About Mikasafe 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Action Category | Aminoglycoside antibiotics |
3,018 People bought this recently